Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M500657200 on February 14, 2005

J. Biol. Chem., Vol. 280, Issue 16, 15587-15594, April 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/16/15587    most recent
M500657200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zoccarato, F.
Right arrow Articles by Alexandre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoccarato, F.
Right arrow Articles by Alexandre, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dopamine-derived Dopaminochrome Promotes H2O2 Release at Mitochondrial Complex I

STIMULATION BY ROTENONE, CONTROL BY Ca2+, AND RELEVANCE TO PARKINSON DISEASE*

Franco Zoccarato, Paola Toscano, and Adolfo Alexandre{ddagger}

From the Dipartimento di Chimica Biologica and the Istituto di Neuroscienze, Sezione di Biomembrane (Consiglio Nazionale delle Ricerche), Università di Padova, Viale G. Colombo 3, 35121 Padova, Italy

Inhibitors of Complex I of the mitochondrial respiratory chain, such as rotenone, promote Parkinson disease-like symptoms and signs of oxidative stress. Dopamine (DA) oxidation products may be implicated in such a process. We show here that the o-quinone dopaminochrome (DACHR), a relatively stable DA oxidation product, promotes concentration (0.1–0.2 µM)- and respiration-dependent generation of H2O2 at Complex I in brain mitochondria, with further stimulation by low concentrations of rotenone (5–30 nM). The rotenone effect required that contaminating Ca2+ (8–10 µM) was not removed. DACHR apparently extracts an electron from the constitutively autoxidizable site in Complex I, producing a semiquinone, which then transfers an electron to O2, generating and then H2O2. Mitochondrial removal of H2O2 monoamine, formed by either oxidase activity or DACHR, was performed largely by glutathione peroxidase and glutathione reductase, which were negatively regulated by low intramitochondrial Ca2+ levels. Thus, the H2O2 formed accumulated in the medium if contaminating Ca2+ was present; in the absence of Ca2+, H2O2 was completely removed if it originated from monoamine oxidase, but was less completely removed if it originated from DACHR. We propose that the primary action of rotenone is to promote extracellular release via activation of NADPH oxidase in the microglia. In turn, oxidizes DA to DACHR extracellularly. (The reaction is favored by the lack of GSH, which would otherwise preferably produce GSH adducts of dopaminoquinone.) Once formed, DACHR (which is resistant to GSH) enters neurons to activate the rotenone-stimulated redox cycle described.


Received for publication, January 19, 2005 , and in revised form, February 11, 2005.

* This work was supported by Ministero dell'Istruzione, dell'Università e della Ricerca Progetti di Ricerca di rilevante Interesse Nazionale 2004 "Apoptosis and Mitochondria: New Targets in Neoplastic, Degenerative, and Immunologic Diseases." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed. Tel.: 39-49-827-6146; Fax: 39-49-807-3310; E-mail: adolfo.alexandre{at}unipd.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeuroscientistHome page
M. A. Mena and J. Garcia de Yebenes
Glial Cells as Players in Parkinsonism: The "Good," the "Bad," and the "Mysterious" Glia
Neuroscientist, December 1, 2008; 14(6): 544 - 560.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
R. M. Solano, M. J. Casarejos, J. Menendez-Cuervo, J. A. Rodriguez-Navarro, J. Garcia de Yebenes, and M. A. Mena
Glial Dysfunction in Parkin Null Mice: Effects of Aging
J. Neurosci., January 16, 2008; 28(3): 598 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bisaglia, S. Mammi, and L. Bubacco
Kinetic and Structural Analysis of the Early Oxidation Products of Dopamine: ANALYSIS OF THE INTERACTIONS WITH {alpha}-SYNUCLEIN
J. Biol. Chem., May 25, 2007; 282(21): 15597 - 15605.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Martirosyan, S. Leonard, X. Shi, B. Griffith, P. Gannett, and J. Strobl
Actions of a Histone Deacetylase Inhibitor NSC3852 (5-Nitroso-8-quinolinol) Link Reactive Oxygen Species to Cell Differentiation and Apoptosis in MCF-7 Human Mammary Tumor Cells
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 546 - 552.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement